NCT05733598
Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT05733598
Title Study of RP2 in Combination With Second-line Therapy in Patients With Locally Advanced or Metastatic HCC
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors Replimune Inc.
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA


No variant requirements are available.